Market research
LID.LSE LiDCO Group Plc
LSE GBP Healthcare
Latest close
As of 29 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 29M
- P/E ratio
- 23.5
- Analyst target
- 9.1
- Dividend yield
- 0.0%
- Beta
- 0.05
Profile
Instrument facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- GB0030546849
- Market cap
- 29M
- P/E ratio
- 23.5
- Analyst target
- 9.1
- Dividend yield
- 0.0%
- Beta
- 0.05
About
About LiDCO Group Plc
LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company provides LiDCOunity, a hemodynamic monitor to support clinical decision making; LiDCOrapid, a monitor that analyses the blood pressure waveform to provide information in surgical and critically ill patients to help with fluid and drug management; LiDCOview that offers clinical researchers and users with beat-to-beat hemodynamic data; LiDCOplus, a hemodynamic monitor, which provides assessment of the hemodynamic status of critical care and surgery patients; and accessories, including blood pressure modules. It also offers various closed and open pressure monitoring sets for use in the ICU, operating department, and Cath labs; and Stimpod NMS 450X, a quantitative neuromuscular blocking agent monitor. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom.
Research context
LiDCO Group Plc appears in PyInvesting’s London Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the LID.LSE discussion.
5 years, 6 months ago
LiDCO Group Plc is currently in a long term downtrend where the price is trading 86.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Based on the above factors, LiDCO Group Plc gets an overall score of 1/5.